Prompt injection test lab: build a 12-step Python harness that scores Claude, GPT, Gemini, Mistral and DeepSeek on 14 OWASP ...
The FDA approved talazoparib plus enzalutamide for HRR-mutated metastatic hormone-sensitive prostate cancer after TALAPRO-3 cut progression risk by 52%. In mHSPC, the cancer has spread outside the ...
About TALZENNA® (talazoparib) TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks ...
T-Mobile is currently running an iPhone 18 promotion that takes $1,000 off the iPhone 18 Pro or Pro Max phone when you sign up for a new line on an Experience Beyond plan and either port in your ...
The Big Pharma has already launched a phase 2 trial of JNJ-6143 at a 50 mg daily dose in around 100 patients with metastatic androgen pathway modulation-resistant prostate cancer (mAPMR), an advanced ...